Gianrico Farrugia, President and CEO at Mayo Clinic, shared a post on LinkedIn about a paper by Andrea L. Cheville et al. published in The Lancet Oncology:
“Results from a new Mayo-led study have revealed how automation through the electronic health record (EHR) can help patients better manage cancer symptoms before they escalate.
Through the Enhanced EHR-Facilitated Cancer Symptom Control Trial (E2C2), automated symptom check-ins and remote support reduced ER visits and improved patients’ emotional well-being.”
Cheryl Willman, Enterprise Executive Director of Mayo Clinic Comprehensive Cancer Center, shared this post, adding:
“Led by Mayo Clinic Comprehensive Cancer Center investigators, Drs. Andrea Cheville and Kathryn Ruddy, the E2C2 national clinical trial – accruing over 50,000 patients – showed that use of digital patient check-ins and remote care teams greatly improved management of cancer symptoms in the home, reducing the need for hospitalization and acute care visits.
Congratulations to this great team for improving cancer patient care and symptom control, bringing new hope and improved healing to our patients.”
Title: Electronic health record-facilitated symptom surveillance and collaborative care intervention in oncology (E2C2): a cluster-randomised, population-level, stepped-wedge, pragmatic trial
Authors: Andrea L Cheville, Jeph Herrin, Deirdre R Pachman, Veronica Grzegorczyk, Kurt Kroenke, Jennifer L Ridgeway, Sarah A Minteer, Jessica D Austin, Joan M Griffin, Linda Chlan, Cindy Tofthagen, Sandra A Mitchell, Ashley Smith, and Kathryn J Ruddy
You can read the Full Article in The Lancet Oncology.
More posts featuring Gianrico Farrugia.
